Rare Cancer News & Clinical Trials » Trial

Trial - Adrenal Cancer (100 unread)

1 2 3

Agnostic Therapy in Rare Solid Tumors

Posted: October 14th, 2024, 11:00pm UTC

Conditions: Urachal Cancer; Parathyroid Carcinoma; Fibrolamellar Carcinoma; Angiosarcoma; Secretory Carcinoma of Breast; Anal Neoplasms; Metaplastic Breast Carcinoma; Translocation Renal Cell Carcinoma; Carcinosarcoma; Small Intestine Neoplasms; Cholangiocarcinoma; Sertoli-Leydig Cell Tumor; Adenoid Cystic Carcinoma; Mesothelioma; Neuroblastoma; Adrenal Gland Neoplasms; Penile Neoplasms; Apocrine Carcinoma; Fibrosarcoma; Cancer of Unknown Primary; Hemangioblastoma; Thyroid Neoplasms; Hepatoblastoma; Fallopian Tube Neoplasms; Leiomyosarcoma; Vaginal Neoplasms; Neurofibrosarcoma; Gallbladder Neoplasms; Osteosarcoma; Biliary Tract Neoplasms; Clear Cell Endometrial Cancer; Yolk Sac Tumor; Vulvar Neoplasms; Kaposi Sarcoma; Ovarian Epithelial Cancer; Soft Tissue Sarcoma; Urethral Neoplasms; Granulosa Cell Tumor; Primitive Neuroectodermal Tumor; Neuroendocrine Tumors; Trophoblastic Tumor
Interventions: Drug: Nivolumab
Sponsors: Instituto do Cancer do Estado de SÃ£o Paulo; Financiadora de Estudos e Projetos
Recruiting
SCINTIX [BgRT} Using RMRS in Solid and Soft Tissue Tumors

Posted: October 10th, 2024, 11:00pm UTC

Conditions: Thoracic Cancer; Head and Neck Cancer; Pelvic Cancer; Hepatobiliary Carcinoma in Situ; Retroperitoneal Cancer; Distributed and Orphan Tumors
Interventions: Device: RefleXion X1 Radiotherapy System [Imaging Only]
Sponsors: RefleXion Medical
Not yet recruiting
Atovaquone Combined with Radiation in Children with Malignant Brain Tumors

Posted: October 3rd, 2024, 11:00pm UTC

Conditions: High-grade Glioma; Medulloblastoma; Diffuse Intrinsic Pontine Glioma; Diffuse Midline Glioma, H3 K27M-Mutant
Interventions: Drug: Atovaquone; Radiation: Radiation Therapy
Sponsors: Emory University; Morningside Foundation/Peach Bowl LegACy Fund
Recruiting
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib

Posted: October 1st, 2024, 11:00pm UTC

Conditions: NSCLC
Interventions: Biological: Blood samples for Hematology; Biological: Blood samples for Chemistry; Biological: Blood sample for liver function tests; Biological: Pregnancy test; Procedure: Tumour assessment; Procedure: Local Ablative Therapy (LAT)
Sponsors: Groupe Francais De Pneumo-Cancerologie
Not yet recruiting
Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years

Posted: September 30th, 2024, 11:00pm UTC

Conditions: Endocrine; Deficiency; Hypothalamo-Pituitary Disorder; Radiotherapy Side Effect
Interventions: Radiation: Blood sample, urine sample, osteodensitometry
Sponsors: University Hospital, Angers
Not yet recruiting
Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block

Posted: September 30th, 2024, 11:00pm UTC

Conditions: Lung Cancer
Interventions: Procedure: Mid-transverse process to pleura block combined with erector spinae block; Procedure: paravertebral block
Sponsors: Cairo University
Not yet recruiting
Pathological Typeï¼ŒGene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism

Posted: September 19th, 2024, 11:00pm UTC

Conditions: Primary Aldosteronism
Interventions: Other: Tissue specimens were stained by histopathology of hematoxylin-eosin
Sponsors: Qifu Li
Recruiting
To Quantify the Impact of Addition of the GAAD Score to Imaging in Patients with Chronic Liver Disease Eligible for HCC Surveillance.

Posted: September 19th, 2024, 11:00pm UTC

Conditions: Cancer, Hepatocellular
Interventions: Diagnostic Test: GAAD score
Sponsors: Erasmus Medical Center
Recruiting
Phase II Study of PD-1 Antibody Combined with Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma

Posted: September 9th, 2024, 11:00pm UTC

Conditions: Adrenocortical Carcinoma
Interventions: Drug: Triprolizumab; Device: rodiotherapy
Sponsors: Sun Yat-sen University
Not yet recruiting
A Randomized Clinical Trial About Use of 3D Laparoscopy Versus 2D Laparoscopy in Adrenal Surgery

Posted: August 28th, 2024, 11:00pm UTC

Conditions: Adrenal Mass; Adrenal Adenoma; Adrenal Gland Neoplasms
Interventions: Procedure: laparoscopic adrenalectomy
Sponsors: University of Palermo
Completed
Institutional Registry of Rare Diseases

Posted: August 27th, 2024, 11:00pm UTC

Conditions: Rare Diseases; Amyloidosis; Sarcoidosis; Phacomatosis; Pheochromocytoma; Paraganglioma; Von Hippel-Lindau Disease; Immunoglobulin G4-Related Disease; Demyelinating Diseases; Inborn Errors of Metabolism; Eosinophilic Gastrointestinal Disorders; Hypertrophic Cardiomyopathy; Gaucher Disease; Congenital Adrenal Hyperplasia; Hereditary Angioedema; Pulmonary Hypertension; Wilson Disease; Vascular Anomalies; Mastocytosis; Multiple Endocrine Neoplasia; Inflammatory Bowel Diseases; Prader-Willi Syndrome; Hirschsprung Disease; Cushing Syndrome
Sponsors: Hospital Italiano de Buenos Aires
Recruiting
Testicular Adrenal Rest Tumor in Congenital Adrenal Hyperplasia Patients Attending Assuit University Children Hospital

Posted: August 21st, 2024, 11:00pm UTC

Conditions: Testicular Adrenal Rest Tumor; Congenital Adrenal Hyperplasia
Sponsors: Assiut University
Not yet recruiting
A Randomized Controlled Trial to Assess the Impact of Live and Recorded Music-Based Interventions on Pre-operative Stress, Mood, Pain and Biomarkers, in Neurosurgical Patients (Music-STAR Trial)

Posted: August 5th, 2024, 11:00pm UTC

Conditions: Stress; Pain
Interventions: Other: Steinway Spirio M recording/player piano
Sponsors: M.D. Anderson Cancer Center
Not yet recruiting
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Posted: August 1st, 2024, 11:00pm UTC

Conditions: Endometrial Neoplasms; Neoplasm Recurrence, Local; Neoplasm Metastasis
Interventions: Drug: Paclitaxel and Cisplatin; Drug: Cadonilimab; Radiation: Radiotherapy
Sponsors: Shandong Cancer Hospital and Institute
Recruiting
Effect of a GnRH Analog on Hepatic Steatosis

Posted: July 26th, 2024, 11:00pm UTC

Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease; Nonalcoholic Fatty Liver; Endometriosis
Interventions: Drug: Goserelin Acetate 3.6 mg inj, implant
Sponsors: Aristotle University Of Thessaloniki; 424 General Military Hospital
Not yet recruiting
CRISAL Study:Cancer Risk In Secreting Adrenal Lesions

Posted: July 25th, 2024, 11:00pm UTC

Conditions: Adrenal Tumor; Adrenal Incidentaloma; Surgery
Sponsors: University of Roma La Sapienza
Recruiting
Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

Posted: July 23rd, 2024, 11:00pm UTC

Conditions: Ovarian Cancer; Antiangiogenic-Associated Hypertension; Adjuvant Bevacizumab; Hypertension
Interventions: Drug: arm A - angiotensin converting enzyme inhibitors (ACEi); Drug: arm B - calcium channel blockers (CCBs); Drug: arm R - angiotensin receptor blockers ARB
Sponsors: Groupe Hospitalier Pitie-Salpetriere; Dr Floriane Jochum, Principal Investigator; Institut Curie
Active, not recruiting
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Posted: July 16th, 2024, 11:00pm UTC

Conditions: Pancreatic Ductal Adenocarcinoma; Cholangiocarcinoma; Gastric Cancer; Bladder Cancer; Hepatocellular Carcinoma; Pheochromocytoma; Ovarian Cancer
Interventions: Drug: [18F]FAPI-74; Drug: [18F]FDG
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
The Plasma Metabolomics Profiling of Primary Aldosteronism

Posted: July 15th, 2024, 11:00pm UTC

Conditions: Primary Aldosteronism; Essential Hypertension; Idiopathic Aldosteronism; Aldosterone-producing Adenoma
Interventions: Diagnostic Test: liquid chromatography-mass spectrometry (LC/MS)
Sponsors: Third Military Medical University
Completed
Probiotics for Depression in Cancer Patients

Posted: July 11th, 2024, 11:00pm UTC

Conditions: Depression; Anxiety Disorder; Probiotics; Gastrointestinal Cancer; Quality of Life; Chemotherapy
Interventions: Dietary Supplement: Psychobiotics; Other: Placebo
Sponsors: Aristotle University Of Thessaloniki
Recruiting
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Posted: July 4th, 2024, 11:00pm UTC

Conditions: Adrenocortical Carcinoma (ACC); Recurrent Adrenocortical Carcinoma (ACC); Recurrent Abdominal Adrenocortical Carcinoma (ACC); Carcinoma, Adrenocortical; Carcinoma, Adrenal Cortical
Interventions: Radiation: Preoperative external beam radiation therapy (EBRT); Procedure: Surgical resection
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
A Giant Myelolipoma.

Posted: June 28th, 2024, 11:00pm UTC

Conditions: Adrenal Myelolipoma
Interventions: Procedure: laparoscopic adrenalectomy
Sponsors: Instituto Mexicano del Seguro Social
Completed
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Posted: June 28th, 2024, 11:00pm UTC

Conditions: Head and Neck Tumors; Kidney Cancers; Small Cell Lung Cancers; Pheochromocytoma/Paragangliomas; Gastrointestinal Neuroendocrine Tumors; Somatostatin Receptor Positive
Interventions: Drug: 68Ga-DOTATATE; Drug: [203Pb]VMT-alpha-NET; Drug: [212Pb]VMT-alpha-NET
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
Synergistic Effects of PD-1 Antibody and Chemotherapy Followed by Surgery in Limited-metastatic G/GEJ Adenocarcinoma

Posted: June 21st, 2024, 11:00pm UTC

Conditions: Gastric Cancer; GastroEsophageal Cancer
Interventions: Procedure: Radical surgery; Drug: PD-1 Monoclonal Antibody; Drug: XELOX Chemotherapy Regimen; Procedure: Local Treatment
Sponsors: Shanghai Zhongshan Hospital
Not yet recruiting
The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)

Posted: June 3rd, 2024, 11:00pm UTC

Conditions: Pheochromocytoma; Paraganglioma
Interventions: Diagnostic Test: FDG-PET Scan
Sponsors: King's College Hospital NHS Trust
Recruiting
Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation

Posted: May 27th, 2024, 11:00pm UTC

Conditions: Neuroendocrine Tumors; MEN1 Mutation
Interventions: Biological: blood sample
Sponsors: Centre Hospitalier Universitaire Dijon
Recruiting
Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Posted: May 24th, 2024, 11:00pm UTC

Conditions: Somatostatin Receptor Positive; Gastrointestinal Neuroendocrine Tumors; Pheochromocytoma; Paragangliomas
Interventions: Drug: 68Ga-DOTATATE; Drug: [203Pb]VMT-alpha-NET; Drug: [212Pb]VMT-alpha-NET
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Posted: April 16th, 2024, 11:00pm UTC

Conditions: Basal Ganglia Germinoma; Central Nervous System Germinoma; Diabetes Insipidus; Pineal Region Germinoma; Suprasellar Germinoma; Thalamic Germinoma
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy; Procedure: Biospecimen Collection; Drug: Carboplatin; Drug: Etoposide; Radiation: Intensity-Modulated Radiation Therapy; Procedure: Lumbar Puncture; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration; Procedure: Surgical Procedure
Sponsors: Children's Oncology Group
Recruiting
Complex Exploratory Study of Alcohol-Associated Hepatitis

Posted: April 10th, 2024, 11:00pm UTC

Conditions: Alcoholic Hepatitis
Sponsors: Pavol Jozef Safarik University; L Pasteur University Hospital; Hospital Agel Kosice-Saca; Technical University in Kosice; Western University; University of Roma La Sapienza
Not yet recruiting
Sphenopalatine Ganglion Block for Postop Pain Management

Posted: April 9th, 2024, 11:00pm UTC

Conditions: Pituitary; Pain, Postoperative
Interventions: Drug: Bupivacaine-Epinephrine 0.5%-1:200,000 Injectable Solution; Drug: Placebo
Sponsors: Hamilton Health Sciences Corporation
Not yet recruiting
$Permalink for 'Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma'$
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Posted: April 4th, 2024, 11:00pm UTC

Conditions: Multiple Myeloma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma
Interventions: Biological: Talquetamab; Drug: Iberdomide; Drug: Dexamethasone; Procedure: Bone Marrow Biopsy
Sponsors: Thomas Martin, MD; Bristol-Myers Squibb; Janssen Research & Development, LLC
Not yet recruiting
Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

Posted: April 3rd, 2024, 11:00pm UTC

Conditions: Mild Autonomous Cortisol Secretion (MACS)
Interventions: Diagnostic Test: Various labs and imaging tests
Sponsors: The Cleveland Clinic; Recordati Rare Diseases
Not yet recruiting
Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.

Posted: April 3rd, 2024, 11:00pm UTC

Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC)
Interventions: Biological: SL-T10; Biological: GX-I7; Biological: Pembrolizumab
Sponsors: SL VAXiGEN
Recruiting
The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy

Posted: April 2nd, 2024, 11:00pm UTC

Conditions: Lung Cancer; Liver Cancer; Pancreatic Cancer; Renal Cell Carcinoma
Interventions: Radiation: SBRT
Sponsors: Peking University Third Hospital
Recruiting
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Posted: March 27th, 2024, 11:00pm UTC

Conditions: Pancreatic Adenocarcinoma; Ampulla of Vater Carcinoma; Adrenocortical Carcinoma; Neuroendocrine Carcinoma; Soft Tissue Sarcoma; Small Bowel Adenocarcinoma; Duodenum Adenocarcinoma; Gastric Adenocarcinoma
Interventions: Drug: Dostarlimab; Drug: Chemotherapy
Sponsors: UNICANCER; National Cancer Institute, France; GlaxoSmithKline
Recruiting
Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma.

Posted: March 26th, 2024, 11:00pm UTC

Conditions: Adrenal Tumor
Interventions: Procedure: laparoscopic right adrenalectomy
Sponsors: Zagazig University
Completed
Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy

Posted: March 22nd, 2024, 11:00pm UTC

Conditions: Myoma;Uterus
Interventions: Drug: Misoprostol 200mcg Tab; Drug: Oxytocin
Sponsors: Cairo University
Recruiting
The Efficacy of Combining Platelet-rich Plasma With Crystallized Phenol in Pilonidal Sinus Disease

Posted: March 22nd, 2024, 11:00pm UTC

Conditions: Pilonidal Sinus
Interventions: Procedure: crystallized phenol + platelet rich plasma application; Procedure: crystallized phenol
Sponsors: Necmi KadÄ±oÄŸlu Hospital
Recruiting
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Posted: March 22nd, 2024, 11:00pm UTC

Conditions: Endocrine Disorders; Adiposity; Pituitary Adenoma; Cushing Syndrome; Acromegaly; Hypopituitarism
Sponsors: IRCCS San Raffaele
Not yet recruiting
Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer

Posted: March 21st, 2024, 11:00pm UTC

Conditions: Mindfulness; Colon Cancer; Females
Interventions: Behavioral: Mindfulness
Sponsors: University of Illinois at Chicago
Recruiting
Physical Attendance Versus Telephone or Video Follow-up in Patients With Non-functioning Pituitary Tumors.

Posted: March 7th, 2024, 1:00am UTC

Conditions: Non-Functional Pituitary Adenoma
Interventions: Behavioral: Telephone-/video follow-up; Behavioral: In-person follow-up
Sponsors: Zealand University Hospital
Not yet recruiting
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort

Posted: February 28th, 2024, 1:00am UTC

Conditions: Carcinoma Adrenal; Carcinoma, Adrenocortical Recurrent
Sponsors: Latin American Cooperative Oncology Group
Not yet recruiting
Prophylactic Double Thermal Ablation After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps

Posted: February 22nd, 2024, 1:00am UTC

Conditions: Colorectal Cancer; Polyp of Colon
Interventions: Procedure: Hybrid Argon Plasma Coagulation (h-APC); Procedure: Snare tip soft coagulation (STSC)
Sponsors: Centre hospitalier de l'UniversitÃ© de MontrÃ©al (CHUM)
Recruiting
Effects of Erector Spina Plan Block and Epidural Analgesia in Whipple Surgery

Posted: February 12th, 2024, 1:00am UTC

Conditions: Pancreatic Cancer
Sponsors: Ankara City Hospital Bilkent
Completed
A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery

Posted: February 9th, 2024, 1:00am UTC

Conditions: Nonfunctional Adrenal Cortex Adenoma; Primary Aldosteronism; Cushing Syndrome
Interventions: Procedure: Tubeless laparoscopic adrenalectomy; Procedure: Drainage tube
Sponsors: Zhe Meng
Recruiting
Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

Posted: February 7th, 2024, 1:00am UTC

Conditions: Hyperaldosteronism; Hypercortisolism; Cushing s Syndrome
Interventions: Drug: [68Ga]Ga-PentixaFor
Sponsors: National Cancer Institute (NCI)
Recruiting
Exercise Intensity on Brain & Mental Health in Stress

Posted: February 7th, 2024, 1:00am UTC

Conditions: Healthy Adults; Adults With Stress-related Symptoms
Interventions: Behavioral: Seated rest; Behavioral: Exercise at moderate intensity; Behavioral: Exercise at vigorous intensity
Sponsors: The Swedish School of Sport and Health Sciences; The Knowledge Foundation; Avonova; SATS; Itrim
Not yet recruiting
Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"

Posted: February 1st, 2024, 1:00am UTC

Conditions: Obesity; Type2diabetes; Lipodystrophy; Infections; Obesity Associated Disorder
Interventions: Dietary Supplement: Mediterranean diet; Dietary Supplement: Melatonin supplementation
Sponsors: Federico II University; University of Roma La Sapienza; University of Pisa; UniversitÃ degli Studi del Piemonte Orientale "Amedeo Avogadro"; University of Rome Foro Italico
Recruiting
Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization

Posted: January 29th, 2024, 1:00am UTC

Conditions: Resistant Hypertension; Secondary Hypertension; Secondary Hypertension to Endocrine Disorders; Primary Aldosteronism
Interventions: Procedure: Selective adrenal artery embolization
Sponsors: First Affiliated Hospital of Chengdu Medical College
Recruiting
Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

Posted: January 29th, 2024, 1:00am UTC

Conditions: Adrenal Tumor; Primary Aldosteronism; Cushing Syndrome; Pheochromocytoma; Adrenal Cortical Carcinoma
Sponsors: Seoul National University Hospital; Asan Medical Center; Seoul National University Bundang Hospital; Samsung Medical Center; Inha University Hospital; Chonnam National University Hospital; Nowon Eulji Medical Center
Recruiting
Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors

Posted: January 29th, 2024, 1:00am UTC

Conditions: Retinoblastoma; Neurocognitive Dysfunction; Health-Related Behavior
Interventions: Diagnostic Test: Neuropsychological assesment; Diagnostic Test: Psychosocial functioning and quality of life (questionnaires); Diagnostic Test: Parental psychosocial functioning (questionnaires)
Sponsors: Amsterdam University Medical Center
Enrolling by invitation
A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

Posted: January 25th, 2024, 1:00am UTC

Conditions: Cerebral Adrenoleukodystrophy (CALD)
Interventions: Other: No Intervention
Sponsors: bluebird bio; Center for International Blood and Marrow Transplant Research
Recruiting
Hemodynamic Instability of Patient With Spontaneous Subarachnoid Hemorrhage

Posted: January 23rd, 2024, 1:00am UTC

Conditions: Subarachnoid Hemorrhage, Spontaneous; Subarachnoid Hemorrhage, Aneurysmal
Interventions: Diagnostic Test: biomarkers
Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
Effect of HIFU on Sleep Quality Measures in Obese Doubled Chin Women

Posted: January 22nd, 2024, 1:00am UTC

Conditions: OBESITY
Interventions: Device: high intensity focused ultrasound; Other: Doubled chin exercises
Sponsors: Cairo University
Recruiting
The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging

Posted: January 17th, 2024, 1:00am UTC

Conditions: Frailty; Frail Elderly Syndrome; Frailty Syndrome; Aging
Interventions: Dietary Supplement: Nicotinamide Riboside (NR); Other: Placebo
Sponsors: Haukeland University Hospital
Not yet recruiting
Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer

Posted: January 15th, 2024, 1:00am UTC

Conditions: NSCLC; NSCLC Stage IV; Oligometastatic Disease; Non Small Cell Lung Cancer; Non Small Cell Lung Cancer Metastatic; EGF-R Positive Non-Small Cell Lung Cancer; NSCLC Stage IV Without EGFR/ALK Mutation; Non-Small Cell Adenocarcinoma; Non-Small Cell Squamous Lung Cancer; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor; Synchronous Metastases; Metachronous Metastasis
Interventions: Radiation: Stereotactic Ablative Radiotherapy
Sponsors: Radiotherapy Oncology Centre "Santa Maria" Hospital; Paola Anselmo,MD; Michelina Casale,PhD; Fabio Trippa,MD
Recruiting
Local Therapy for Oligometastatic Esophageal Squamous Cell Cancer Patients Treated With PD-1 Inhibitor: a Prospective, Randomized, Phase III Clinical Trial.

Posted: January 4th, 2024, 1:00am UTC

Conditions: Esophageal Squamous Cell Carcinoma; Oligometastatic Disease; Radiotherapy
Interventions: Combination Product: PD-1 inhibitor+/- chemotherapy combined with local therapy; Drug: systemic therapy alone
Sponsors: Fudan University
Recruiting
Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer

Posted: December 7th, 2023, 1:00am UTC

Conditions: Pancreatic Cancer Non-resectable; Tumor Pancreas; Pain Cancer
Interventions: Procedure: EUS-guided coeliac ganglion neurolysis / celiac plexus neurolysis
Sponsors: Chinese University of Hong Kong
Recruiting
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Posted: November 21st, 2023, 1:00am UTC

Conditions: Adrenal Cortical Carcinoma; Medullary Thyroid Cancer; Thymic Neuroendocrine Carcinoma; Pancreatic Neuroendocrine Tumor
Interventions: Biological: individualized mRNA neoantigen vaccine (mRNA-0523-L001)
Sponsors: Shanghai Jiao Tong University School of Medicine
Recruiting
Metastasis-directed Therapy for Oligometastases of Breast Cancer

Posted: November 16th, 2023, 1:00am UTC

Conditions: Breast Cancer; Oligometastasis; Metastatic Breast Cancer
Interventions: Drug: Systemic therapy for 12 weeks after primary registration; Procedure: Radiation therapy (SBRT/conventional RT); Procedure: Surgery; Drug: Same systemic therapy after secondary registration
Sponsors: Tokyo Medical and Dental University
Recruiting
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Posted: November 15th, 2023, 1:00am UTC

Conditions: Low Grade Glioma; Malignant Brain Glioma; Malignant Brain Neoplasm; Meningioma
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Dexamethasone; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration
Sponsors: Emory University; National Cancer Institute (NCI)
Not yet recruiting
Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn

Posted: October 19th, 2023, 11:00pm UTC

Conditions: Hyperaldosteronism; Hypertension; Aldosterone-producing Adenoma; Aldosteronism; Aldosterone Disorder; Essential Hypertension; Bilateral Adrenal Hyperplasia; Conn Adenoma
Interventions: Procedure: Skin Biopsy; Procedure: Video-laparoscopic adrenalectomy
Sponsors: University Hospital Padova
Recruiting
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

Posted: October 4th, 2023, 11:00pm UTC

Conditions: Adrenocortical Carcinoma; ACC; Metastatic Adrenocortical Carcinoma
Interventions: Radiation: Ablative Radiotherapy; Drug: Pembrolizumab
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
Tranexamic Acid in Nasal Mohs Reconstruction

Posted: September 28th, 2023, 11:00pm UTC

Conditions: Postoperative Bleeding; Skin Cancer Face
Interventions: Drug: Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine); Drug: Control (1% lidocaine with 1:100,000 epinephrine)
Sponsors: Vanderbilt University Medical Center
Recruiting
MT2022-01: MSCs for ALD

Posted: September 11th, 2023, 11:00pm UTC

Conditions: Cerebral Adrenoleukodystrophy
Interventions: Biological: Mesenchymal stem cells (IV-MSC)
Sponsors: Masonic Cancer Center, University of Minnesota
Suspended
Core Stabilization Exercise Therapy in Chronic Lower Back Back Management in Community Dwelling Older Adults

Posted: September 8th, 2023, 11:00pm UTC

Conditions: Chronic Low-back Pain; Older Adults; Core Stabilization Exercise Therapy
Interventions: Behavioral: core stabilization exercise
Sponsors: The Hong Kong Polytechnic University
Recruiting
Phase 1 Study of 68Ga-R8760

Posted: August 21st, 2023, 11:00pm UTC

Conditions: Adrenocortical Carcinoma
Interventions: Drug: 68Ga-R8760 injection at pre-defined dose levels; Drug: 68Ga-R8760 injection
Sponsors: Radionetics Oncology
Active, not recruiting
Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)

Posted: June 22nd, 2023, 11:00pm UTC

Conditions: Adrenocortical Carcinoma
Interventions: Drug: Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG; Drug: Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo
Sponsors: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Recruiting
Intercostal Cryoanalgesia for Acute Pain After VATS Lung Resection

Posted: June 9th, 2023, 11:00pm UTC

Conditions: Thoracic Surgery; Video-Assisted; Cryotherapy Effect; Paravertebral Block
Interventions: Procedure: Cryoanalgesia AND single-injection paravertebral block; Procedure: Single-injection paravertebral block
Sponsors: Centre hospitalier de l'UniversitÃ© de MontrÃ©al (CHUM)
Recruiting
Intercostal Cryoanalgesia for Chronic Pain After VATS Lung Resection

Posted: June 1st, 2023, 11:00pm UTC

Conditions: Cryotherapy Effect; Chronic Pain; Lung Cancer; Surgery
Interventions: Procedure: Cryoanalgesia AND single-injection paravertebral block; Procedure: Single-injection paravertebral block
Sponsors: Centre hospitalier de l'UniversitÃ© de MontrÃ©al (CHUM)
Recruiting
18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma

Posted: May 23rd, 2023, 11:00pm UTC

Conditions: Hepatocellular Carcinoma
Interventions: Diagnostic Test: 18F-FDGal PET/CT or PET/MRI
Sponsors: University of Aarhus
Recruiting
Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers

Posted: April 28th, 2023, 11:00pm UTC

Conditions: Squamous Cell Carcinoma of the Head and Neck; Paclitaxel; Carboplatin; Nivolumab
Interventions: Drug: GCP intratumoral catheter
Sponsors: Centre Hospitalier Universitaire, Amiens
Not yet recruiting
Ramadan Fasting in Secondary Adrenal Insufficiency Patients

Posted: April 25th, 2023, 11:00pm UTC

Conditions: Secondary Adrenal Insufficiency; Fasting, Intermittent
Interventions: Behavioral: education and drug adjustement
Sponsors: Hopital La Rabta
Active, not recruiting
Colonoscopic Sucralfate Spray in Prevention of Delayed Polypectomy Bleeding

Posted: April 18th, 2023, 11:00pm UTC

Conditions: Bleeding
Interventions: Drug: Sucralfate
Sponsors: National Cheng-Kung University Hospital
Recruiting
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Posted: April 7th, 2023, 11:00pm UTC

Conditions: Cushing Syndrome; Cushing Disease; Ectopic ACTH Syndrome
Interventions: Drug: CRN04894
Sponsors: Crinetics Pharmaceuticals Inc.
Recruiting
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Posted: March 24th, 2023, 11:00pm UTC

Conditions: Oligometastatic Disease; Oligoprogression; Toxicity Due to Radiotherapy; Quality of Life
Interventions: Radiation: Single fraction SABR; Radiation: Multiple fraction SABR; Other: QoL reporting alone; Other: QoL reporting, symptom screen and healthcare provider intervention
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; Tom Baker Cancer Centre; Princess Margaret Hospital, Canada
Not yet recruiting
Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE)

Posted: March 6th, 2023, 1:00am UTC

Conditions: Cancer; Adrenal
Interventions: Other: Blood sample; Other: Urine sample; Other: Tumor sample
Sponsors: Assistance Publique - HÃ´pitaux de Paris; National Cancer Institute, France
Recruiting
The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

Posted: January 27th, 2023, 1:00am UTC

Conditions: Pheochromocytoma; Paraganglioma; Adrenalectomy; Status; Adrenergics Causing Adverse Effects in Therapeutic Use
Interventions: Drug: Phenoxybenzamine
Sponsors: Seoul National University Hospital
Recruiting
Baby Detect : Genomic Newborn Screening

Posted: January 18th, 2023, 1:00am UTC

Conditions: Congenital Adrenal Hyperplasia; Familial Hyperinsulinemic Hypoglycemia 1; Phosphoglucomutase 1 Deficiency; Maturity Onset Diabetes of the Young; Cystic Fibrosis; Hypophosphatasia, Infantile; Congenital Hypothyroidism; Deficit in Anterior Pituitary Function and Variable Immunodeficiency; Pituitary Hormone Deficiency, Combined; Diamond Blackfan Anemia; Wiskott-Aldrich Syndrome; Fanconi Anemia; Hemophilia A; Hemophilia B; Glucose 6 Phosphate Dehydrogenase Deficiency; Alpha-Thalassemia; Sickle Cell Disease; Shwachman-Diamond Syndrome; Alpha 1-Antitrypsin Deficiency; Inflammatory Bowel Disease 25, Autosomal Recessive; Wilson Disease; Progressive Familial Intrahepatic Cholestasis; Crigler-Najjar Syndrome; Familial Chylomicronemia; Lysosomal Acid Lipase Deficiency; Familial Hemophagocytic Lymphocytosis; Griscelli Syndrome; Chediak-Higashi Syndrome; Severe Congenital Neutropenia; Severe Combined Immune Deficiency; Chronic Granulomatous Disease; Menkes Disease; Adrenoleukodystrophy; Smith-Lemli-Opitz Syndrome; Ataxia With Vitamin E Deficiency; Thiamine Metabolism Dysfunction Syndrome 5 (Episodic Encephalopathy Type); Thiamine Metabolism Dysfunction Syndrome 4 (Bilateral Striatal Degeneration and Progressive Polyneuropathy Type); Thiamine-Responsive Megaloblastic Anemia; Thiamine Metabolism Dysfunction Syndrome 2; Deficiency of GOT2; Cerebral Folate Transport Deficiency; Segawa Syndrome, Autosomal Recessive; Congenital Myasthenic Syndrome; Metachromatic Leukodystrophy; Sepiapterin Reductase Deficiency; Dopamine Beta Hydroxylase Deficiency; Glut1 Deficiency Syndrome; Late-Infantile Neuronal Ceroid Lipofuscinosis; Aromatic L-amino Acid Decarboxylase Deficiency; Charcot-Marie-Tooth Disease, Type 6C; Hereditary Hyperekplexia; Brain Dopamine-Serotonin Vesicular Transport Disease; Very Long Chain Hydroxy Acyl Dehydrogenase Deficiency; Tyrosinemia, Type I; Disaccharide Intolerance I; Beta Ketothiolase Deficiency; Phosphoglycerate Dehydrogenase Deficiency; Succinyl-Coa:3-Ketoacid Coa-Transferase Deficiency; Pyridoxine-5'-Phosphate Oxidase Deficiency; Pyridoxine-Dependent Epilepsy; Propionic Acidemia; Pompe Disease; Phenylalanine Hydroxylase Deficiency; Ornithine Transcarbamylase Deficiency; N Acetyl Glutamate Synthetase Deficiency; Riboflavin Deficiency; Maple Syrup Urine Disease; Medium Chain Acyl CoA Dehydrogenase Deficiency; Malonic Acidemia; Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency; Isovaleric Acidemia; Phosphoserine Aminotransferase Deficiency; Phosphoserine Phosphatase Deficiency; Hyperornithinemia-Hyperammonemia-Homocitrullinuria; S-Adenosylhomocysteine Hydrolase Deficiency; Mucopolysaccharidosis VII; Mucopolysaccharidosis VI; Mucopolysaccharidosis IV A; Mucopolysaccharidosis II; Mucopolysaccharidosis I; Transcobalamin Deficiency; Isolated Methylmalonic Acidemia; Cobalamin Deficiency; Homocystinuria; Holocarboxylase Synthetase Deficiency; Fanconi Bickel Syndrome; Glycogen Storage Disease; Glycine Encephalopathy; Glutaric Acidemia I; Glucose Galactose Malabsorption; Gaucher Disease, Type 1; Galactosemias; Fructosemia; Fructose-1,6-Diphosphatase Deficiency; Carbamoyl Phosphate Synthase 1 Deficiency; Citrullinemia Type II; Citrullinemia 1; Creatine Deficiency Syndrome; Systemic Primary Carnitine Deficiency; Carnitine Palmitoyltransferase Deficiency 2; Carnitine Palmitoyltransferase Deficiency 1; Carnitine Acylcarnitine Translocase Deficiency; Riboflavin Transporter Deficiency; Branched-Chain Keto Acid Dehydrogenase Kinase Deficiency; Andersen Tawil Syndrome; Timothy Syndrome; Jervell-Lange Nielsen Syndrome; Catecholaminergic Polymorphic Ventricular Tachycardia; Familial Hypertrophic Cardiomyopathy Type 4; Pseudohypoaldosteronism, Type II; Pseudohypoaldosteronism Type 1; Primary Hyperoxaluria; X Linked Hypophosphatemia; Hereditary Nephrogenic Diabetes Insipidus; Cystinosis; Congenital Nephrotic Syndrome, Finnish Type; Alport Syndrome; Hereditary Retinoblastoma; Biotinidase Deficiency; Aciduria, Argininosuccinic; Argininemia; Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of; 3-Hydroxy 3-Methyl Glutaric Aciduria; 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency
Sponsors: Centre Hospitalier Universitaire de Liege; Centre Hospitalier RÃ©gional de la Citadelle; University of Liege; Sanofi; Orchard Therapeutics; Takeda; Zentech-Lacar Company; Leon Fredericq Foundation
Recruiting
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

Posted: December 15th, 2022, 1:00am UTC

Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Locally Advanced Esophageal Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Fluorouracil; Drug: Leucovorin; Drug: Oxaliplatin; Biological: Pembrolizumab; Drug: Propranolol Hydrochloride; Other: Questionnaire Administration
Sponsors: Roswell Park Cancer Institute; United States Department of Defense
Recruiting
Efficacy and Safety of HYbrid Argon Plasma Coagulation Technique in Patients With Barrett's Esophagus-Related Dysplasia

Posted: December 9th, 2022, 1:00am UTC

Conditions: Barrett's Esophagus
Interventions: Device: Hybrid Argon Plasma Coagulation System
Sponsors: Istituto Clinico Humanitas
Recruiting
The Effects of oXiris in Cardiogenic Shock Requiring VA-ECMO

Posted: December 8th, 2022, 1:00am UTC

Conditions: Cardiogenic Shock
Interventions: Device: oXiris membrane; Diagnostic Test: Blood tests
Sponsors: Samsung Medical Center
Completed
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Posted: December 6th, 2022, 1:00am UTC

Conditions: Essential Hypertension; Liver Cancer; Nasopharyngeal Cancer; Pancreatic Cancer; Lung Cancer; Chronic Kidney Diseases; Acute Coronary Syndrome; Epilepsy; Gastric Cancer; Primary Aldosteronism; Subclinical hypothyroÃ¯dism
Interventions: Other: no intervention
Sponsors: Zhujiang Hospital; National Natural Science Foundation of China
Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma

Posted: December 2nd, 2022, 1:00am UTC

Conditions: Adrenocortical Carcinoma
Interventions: Drug: Mitotane; Drug: Pembrolizumab
Sponsors: M.D. Anderson Cancer Center
Completed
Comparison of Three Different Puncture Techniques in EBUS-TBNA

Posted: November 28th, 2022, 1:00am UTC

Conditions: Lung Cancer; Sarcoidosis; Tuberculosis
Interventions: Procedure: Endobronchial ultrasound-guided transbronchial needle Slow-pull capillary sampling; Procedure: Endobronchial ultrasound-guided transbronchial needle aspiration; Procedure: Endobronchial ultrasound-guided transbronchial needle capillary sampling
Sponsors: Beijing Friendship Hospital
Recruiting
Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients

Posted: November 14th, 2022, 1:00am UTC

Conditions: Melanoma
Interventions: Other: AEP Group Walking Sessions; Other: CEP Group Walking Sessions
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Completed
Pulsed Radiofrequency of S2-4 Versus Ganglion Impar Neurolysis for Severe Perianal and Perineal Pain in Cancer Patients

Posted: October 24th, 2022, 11:00pm UTC

Conditions: Analgesia
Interventions: Procedure: Ganglion Impar Neurolysis; Procedure: Bilateral S2, S3 and S4 Pulsed radiofrequency
Sponsors: National Cancer Institute, Egypt
Completed
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Posted: September 10th, 2022, 11:00pm UTC

Conditions: Medulloblastoma
Interventions: Procedure: Surgical resection; Procedure: Ommaya/VPS; Drug: Methotrexate; Drug: Cisplatin; Drug: Vincristine; Drug: Cyclophosphamide; Drug: Carboplatin; Drug: Topotecan; Drug: Etoposide; Drug: Pegfilgrastim; Drug: Filgrastim; Radiation: Irradiation; Other: Educational and Media Intervention; Other: SOC, Educational and Media Intervention
Sponsors: St. Jude Children's Research Hospital
Recruiting
Translational Research Center in Lung Cancer Disparities (TRACER) Project 2

Posted: August 5th, 2022, 11:00pm UTC

Conditions: Smoking; Smoking Behaviors; Smoking Cessation; Stress Reaction
Sponsors: Virginia Commonwealth University; City of Hope Medical Center; Medical University of South Carolina; National Cancer Institute (NCI)
Recruiting
Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults

Posted: July 19th, 2022, 11:00pm UTC

Conditions: Craniopharyngioma, Child; Craniopharyngioma; Recurrent Craniopharyngioma
Interventions: Drug: Nivolumab; Drug: Tovorafenib
Sponsors: Sabine Mueller, MD, PhD; Bristol-Myers Squibb; Day One Biopharmaceuticals, Inc.
Recruiting
Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

Posted: July 7th, 2022, 11:00pm UTC

Conditions: Primary Aldosteronism; Adrenal Cushing Syndrome; Pheochromocytoma; Endocrine Neoplasia
Interventions: Diagnostic Test: Adrenal aldosterone synthase (CYP11B2) staining; Diagnostic Test: Adrenal cortisol synthase (CYP11B1) staining; Diagnostic Test: Histopathological analysis
Sponsors: Helsinki University Central Hospital; Finnish Institute for Health and Welfare; University of Helsinki; Tampere University Hospital; Tampere University
Active, not recruiting
SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor

Posted: June 29th, 2022, 11:00pm UTC

Conditions: Autonomous Cortisol Secretion (ACS); ACTH-Independent Cushing Syndrome; ACTH-Independent Adrenal Cushing Syndrome, Somatic
Interventions: Drug: SPI-62 dose
Sponsors: Sparrow Pharmaceuticals
Active, not recruiting
Prebiotic and Probiotic Modulation of the Gut Microbiota-gut-brain Axis During Acute Stress

Posted: May 26th, 2022, 11:00pm UTC

Conditions: Stress Physiology
Interventions: Dietary Supplement: Probiotic; Dietary Supplement: Prebiotic; Other: Placebo
Sponsors: United States Army Research Institute of Environmental Medicine; United States Army Combat Capabilities Development Command Soldier Center; United States Air Force Research Laboratory
Recruiting
Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

Posted: May 19th, 2022, 11:00pm UTC

Conditions: Endogenous Cushing's Syndrome
Interventions: Drug: Osilodrostat
Sponsors: RECORDATI GROUP
Active, not recruiting
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

Posted: May 10th, 2022, 11:00pm UTC

Conditions: Primary Aldosteronism; Aldosterone-Producing Adenoma; Hypercortisolism
Interventions: Procedure: EUS-RFA of left adrenal tumour in PA with AVS-verified left lateralisation; Procedure: EUS-RFA of left adrenal tumour in PA, "debulking group"; Procedure: EUS-RFA of left adrenal tumour in MACS with AVS-verified left lateralisation; Procedure: EUS-RFA of left adrenal tumour in MACS with bilateral overproduction, "debulking group
Sponsors: Haukeland University Hospital
Recruiting
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

Posted: April 26th, 2022, 11:00pm UTC

Conditions: Cancer
Interventions: Behavioral: Survivorship Care Plan-Personal Health Record (SCP-PHR)
Sponsors: Indiana University; National Cancer Institute (NCI)
Recruiting
Tranexamic Acid During Colonic Endoscopic Resection Procedures

Posted: April 26th, 2022, 11:00pm UTC

Conditions: Colon Neoplasm
Interventions: Drug: Tranexamic acid; Drug: Standard
Sponsors: Assaf-Harofeh Medical Center
Recruiting
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

Posted: April 1st, 2022, 11:00pm UTC

Conditions: Cushing's Syndrome I; Cushing Disease Due to Increased ACTH Secretion; Cortisol Excess; Cortisol; Hypersecretion; Cortisol Overproduction; Ectopic ACTH Secretion
Interventions: Drug: SPI-62; Drug: Placebo
Sponsors: Sparrow Pharmaceuticals
Active, not recruiting
Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures

Posted: March 24th, 2022, 11:00pm UTC

Conditions: Eyelid Tumor; Eyelid Bump; Eyelid Deformity; Eyelid Abscess; Eyelid Boil; Eyelid Papilloma; Anesthesia, Local; Ophthalmology
Interventions: Drug: 0.9% Bacteriostatic Local Anesthetic Injection; Drug: 1% Lidocaine with 1:100,000 epinephrine Local Anesthetic Injection; Procedure: Eyelid Lesion Removal
Sponsors: University of California, San Francisco
Completed
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

Posted: February 14th, 2022, 1:00am UTC

Conditions: Neuroendocrine Tumors; Carcinoma, Neuroendocrine
Sponsors: National Cancer Institute (NCI)
Recruiting

1 2 3

← PubMed - Adrenocortical Carcinoma Trial - Adrenocortical Carcinoma →

Rare Cancer News & Clinical Trials » Trial - Adrenal Cancer

Feeds

Trial - Adrenal Cancer (100 unread)

Posted: October 14th, 2024, 11:00pm UTC

Posted: October 10th, 2024, 11:00pm UTC

Posted: October 3rd, 2024, 11:00pm UTC

Posted: October 1st, 2024, 11:00pm UTC

Posted: September 30th, 2024, 11:00pm UTC

Posted: September 30th, 2024, 11:00pm UTC

Posted: September 19th, 2024, 11:00pm UTC

Posted: September 19th, 2024, 11:00pm UTC

Posted: September 9th, 2024, 11:00pm UTC

Posted: August 28th, 2024, 11:00pm UTC

Posted: August 27th, 2024, 11:00pm UTC

Posted: August 21st, 2024, 11:00pm UTC

Posted: August 5th, 2024, 11:00pm UTC

Posted: August 1st, 2024, 11:00pm UTC

Posted: July 26th, 2024, 11:00pm UTC

Posted: July 25th, 2024, 11:00pm UTC

Posted: July 23rd, 2024, 11:00pm UTC

Posted: July 16th, 2024, 11:00pm UTC

Posted: July 15th, 2024, 11:00pm UTC

Posted: July 11th, 2024, 11:00pm UTC

Posted: July 4th, 2024, 11:00pm UTC

Posted: June 28th, 2024, 11:00pm UTC

Posted: June 28th, 2024, 11:00pm UTC

Posted: June 21st, 2024, 11:00pm UTC

Posted: June 3rd, 2024, 11:00pm UTC

Posted: May 27th, 2024, 11:00pm UTC

Posted: May 24th, 2024, 11:00pm UTC

Posted: April 16th, 2024, 11:00pm UTC

Posted: April 10th, 2024, 11:00pm UTC

Posted: April 9th, 2024, 11:00pm UTC

Posted: April 4th, 2024, 11:00pm UTC

Posted: April 3rd, 2024, 11:00pm UTC

Posted: April 3rd, 2024, 11:00pm UTC

Posted: April 2nd, 2024, 11:00pm UTC

Posted: March 27th, 2024, 11:00pm UTC

Posted: March 26th, 2024, 11:00pm UTC

Posted: March 22nd, 2024, 11:00pm UTC

Posted: March 22nd, 2024, 11:00pm UTC

Posted: March 22nd, 2024, 11:00pm UTC

Posted: March 21st, 2024, 11:00pm UTC

Posted: March 7th, 2024, 1:00am UTC

Posted: February 28th, 2024, 1:00am UTC

Posted: February 22nd, 2024, 1:00am UTC

Posted: February 12th, 2024, 1:00am UTC

Posted: February 9th, 2024, 1:00am UTC

Posted: February 7th, 2024, 1:00am UTC

Posted: February 7th, 2024, 1:00am UTC

Posted: February 1st, 2024, 1:00am UTC

Posted: January 29th, 2024, 1:00am UTC

Posted: January 29th, 2024, 1:00am UTC

Posted: January 29th, 2024, 1:00am UTC

Posted: January 25th, 2024, 1:00am UTC

Posted: January 23rd, 2024, 1:00am UTC

Posted: January 22nd, 2024, 1:00am UTC

Posted: January 17th, 2024, 1:00am UTC

Posted: January 15th, 2024, 1:00am UTC

Posted: January 4th, 2024, 1:00am UTC

Posted: December 7th, 2023, 1:00am UTC

Posted: November 21st, 2023, 1:00am UTC

Posted: November 16th, 2023, 1:00am UTC

Posted: November 15th, 2023, 1:00am UTC

Posted: October 19th, 2023, 11:00pm UTC

Posted: October 4th, 2023, 11:00pm UTC

Posted: September 28th, 2023, 11:00pm UTC

Posted: September 11th, 2023, 11:00pm UTC

Posted: September 8th, 2023, 11:00pm UTC

Posted: August 21st, 2023, 11:00pm UTC

Posted: June 22nd, 2023, 11:00pm UTC

Posted: June 9th, 2023, 11:00pm UTC

Posted: June 1st, 2023, 11:00pm UTC

Posted: May 23rd, 2023, 11:00pm UTC

Posted: April 28th, 2023, 11:00pm UTC

Posted: April 25th, 2023, 11:00pm UTC